Paliwal P, Radha V, Swarup G (2007) Regulation of p73 by Hck through kinase-dependent and independent mechanisms. BMC Mol Biol 8, 45 17535448

This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.

Click on the protein name to open the protein page, and on the RSD number to open the site page.

Download

Y28-p - p73 (human) ▲

Modsite: SLEPDStyFDLPQSS SwissProt Entrez-Gene Orthologous residues p73 (human): Y28‑p, p73 iso2 (human): Y28‑p, p73 iso8 (human): ‑, p73 iso10 (human): ‑, p73 (mouse): Y25‑p Characterization Methods used to characterize site in vivo:  mutation of modification site, phospho-antibody, western blotting Disease tissue studied:  bone cancer Relevant cell lines - cell types - tissues:  COS (fibroblast), HeLa (cervical), Saos-2 (bone cell) Cellular systems studied:  cell lines Species studied:  green monkey Upstream Regulation Potential in vivo enzymes for site:  Type Enzyme Evidence Notes KINASE Src (human) transfection of inactive enzyme, transfection of wild-type enzyme KINASE Hck (human) transfection of wild-type enzyme, co-immunoprecipitation